Filtyp
Understanding the very first pathological events at the molecular level is key to developing treatments preventing neurodegenerative diseases. With a novel microspectroscopy approach combining optical and photothermal imaging, MultiPark researchers can follow early alterations of proteins involved in Alzheimer’s disease, before neurons degenerate. Their discoveries are published in the Journal of
Every year, the patient organization Parkinson Skåne organizes a half-day of themed lectures on Parkinson's disease. The strategic research area, MultiPark, usually sponsors the moderator costs and contributes with research talks. In addition, the researchers arrange four times a year the well-attended popular science seminar evenings MultiPark café for members of the patient organization. This co
https://www.multipark.lu.se/article/extended-cooperation-between-multipark-and-patient-organization-parkinson-skane - 2025-10-31
January 2024 is the start of a new electoral term for MultiPark’s management. While Angela Cenci Nilsson will remain the coordinator, Oskar Hansson will be replaced for the next three years. The vice coordinator's mission will be shared between a health scientist and a clinician. Maria H. Nilsson and Per Odin explain how they will contribute to leading MultiPark. According to MultiPark’s steering
https://www.multipark.lu.se/article/double-multipark-gets-two-new-vice-coordinators - 2025-10-31
Intensive efforts are being made in medical research to discover the genomic causes of undiagnosed hereditary diseases. Persistent work and new technology are providing answers to several previously unsolved, enigmatic neurological disorders. Spinocerebellar ataxia type 4 was one of these, but now a research team in Lund, Sweden, have identified the gene that is responsible. Almost half a million
To stimulate the international recruitment of excellent young researchers, Lund University has launched a call for positions as associate senior lecturers (biträdande universitetslektor) reserved for candidates with postdoctoral research experience in institutes outside of Sweden (and not having held a position of scholarship in Sweden after February 15, 2020). The candidates should be academicall
https://www.multipark.lu.se/article/lund-university-launches-international-recruitment-programme-young-researchers - 2025-10-31
Researchers have succeeded in restoring lost brain function in mouse models of stroke using small molecules that in the future could potentially be developed into a stroke therapy. “Communication between nerve cells in large parts of the brain changes after a stroke and we show that it can be partially restored with the treatment", says Tadeusz Wieloch, senior professor at Lund University who led
https://www.multipark.lu.se/article/new-study-lost-brain-function-restored-after-stroke - 2025-10-31
MultiPark researchers have discovered a new promising pharmacological approach stimulating recovery after stroke. Professor Tadeusz Wieloch tells about how the MultiPark Innovation Office supported the first steps in converting their academic research findings into something with commercial potential that may finally benefit the patients. Around 80% of people who suffer a stroke permanently lose s
https://www.multipark.lu.se/article/turning-academic-discoveries-therapies-how-multipark-innovation-office-helps - 2025-10-31
Raquel Garza Gómez is a Ph.D. student at Lund University, who will be defending her thesis on January 19, 2024. With a background in computational biology, Raquel's research focuses on studying the role of transposable elements in the human brain. Transposable elements refer to DNA sequences capable of moving from one part of the genome to another. Her research aims to provide a better understandi
The United Neuroscience Campus (UNC) is a partnership between MultiPark and the Centre for Transdisciplinary Neurosciences Rostock (CTNR) at the University Medical Centre Rostock, which started by a signed agreement (“Memorandum of understanding”) in May 2022. The UNC is a virtual campus beyond the Lund and Rostock locations on key neuroscience topics. It aims to increase the cooperation and mobil
https://www.multipark.lu.se/article/united-neuroscience-campus-lund-rostock-unc - 2025-10-31
MultiPark is proud to co-fund and support World Parkinson's Day in Lund - 11 April 2024. World Parkinson's Day (WPD) is a global healthcare event celebrated on the 11th of April every year. It brings together all of us who care about Parkinson´s disease, in different capacities, around the world. To celebrate WPD, MultiPark and Parkinson Skåne have co-organised a symposium where frontline overview
https://www.multipark.lu.se/article/world-parkinsons-day-lund - 2025-10-31
Future Faculty is proud to present the 2024 Minerva Award to Dr Laura Wisse, Associate Professor of Diagnostic Radiology at the Department of Clinical Sciences in Lund. Future Faculty is proud to present the 2024 Minerva Award to Dr Laura Wisse, Associate Professor of Diagnostic Radiology at the Department of Clinical Sciences in Lund.The Minerva award selection committee’s motivation for the choi
https://www.multipark.lu.se/article/minerva-leadership-award-winner-2024 - 2025-10-31
The Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research was established in 2012 in memory of Van Andel Institute founder Jay Van Andel, who battled Parkinson’s disease for a decade before his death in 2004. The award is given to scientists who have made outstanding contributions to Parkinson’s disease research and who have positively impacted human health. Yesterday, on
Future Faculty has awarded the 2024 Minerva Award to Laura Wisse, Associate Professor. Congrats to the Minerva Leadership Award, Laura Wisse, Associate Professor and PI!"Thank you, I feel very honored to receive the award as a relatively young PI and will try my best to live up to this prize in the future, to honor good academic leadership."What do you think is a good leader?"In my opinion, a goo
Higher dose cohort initiated after positive early safety evaluation in Parkinson's therapy. After a positive initial safety evaluation, the pioneering STEM-PD clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Parkinson’s disease aimed at replacing the dopamine cells lost to the disease with healthy ones derived
https://www.multipark.lu.se/article/update-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease - 2025-10-31
By analysing small microvesicles that cells release to communicate with their surroundings in the blood, researchers at Lund University map what happens in the brains of stroke patients. The study published in the scientific journal Stroke expands our understanding of stroke and opens doors to new treatment strategies. schemic stroke, caused by a blood clot in the brain, is the leading cause of d
https://www.multipark.lu.se/article/cell-specific-biomarkers-blood-reflect-what-happens-brain-during-stroke - 2025-10-31
Popular Science SummaryWe are all familiar with the idea that living organisms are made of atoms and molecules. But not everyone knows that one of those molecules that are crucial for our lives are proteins. And no, they aren’t just something we have to eat. Proteins are an essential molecule which form our cells, together with fat, sugars, and nucleic acids. Proteins are the workforce of the cell
A commercially available blood test has now been trialled in routine healthcare. “The blood test showed about 90% reliability even in primary care. This may have major implications for all those individuals who seek help for memory loss and suspected Alzheimer’s,” say the researchers at Lund University in Sweden behind the study. Alzheimer’s disease affects one in five women and one in ten men ove
https://www.multipark.lu.se/article/groundbreaking-alzheimers-blood-test-proves-highly-effective-primary-healthcare - 2025-10-31
Neuroinflammation plays a significant role in neurodegenerative disorders. That is why MultiPark researchers collaborates across research teams. ”Neuroinflammatory pathways in neurodegenerative diseases” is a new special interest group (SIG) to elucidate molecular and genetic aspects in a rapidly growing research area. Malin Wennström explains how she convenes the joint effort. Can you briefly des
https://www.multipark.lu.se/article/neuroinflammatory-pathways-neurodegenerative-diseases-special-interest-group - 2025-10-31
Digital tools within healthcare are developing faster than ever before. Therefore, MultiPark researchers gather across groups to develop implementable tools for the diagnosis and prognosis of neurodegenerative disorders. “Digital tools to reliably evaluate cognitive and neurological symptoms” is a new special interest group (SIG) convened by Maria H Nilsson. Here, she tells about the group’s visio
https://www.multipark.lu.se/article/digital-tools-evaluate-symptoms-special-interest-group - 2025-10-31
Recent discoveries have shown that it is possible to convert one cell type into another, typically by forced expression of lineage specific transcription factors. That is why MultiPark researchers with expertise in reprogramming gather across research groups. Cellular reprogramming is a new special interest group (SIG) addressing scientific and technological needs to apply these methods in researc
https://www.multipark.lu.se/article/cellular-reprogramming-special-interest-group - 2025-10-31
